Illustration of SpaceOAR Hydrogel

SpaceOAR Vue™ Hydrogel

Radiopaque Perirectal Spacer for Radiation Therapy

Visibly Different video

Visibly Different

SpaceOAR Vue Hydrogel is the next-generation hydrogel spacer that offers enhanced visibility via CT scan

 


 

SpaceOAR Vue Hydrogel in different image modalities.


 
T2-weighted Magnetic Resonance images*
T2-weighted Magnetic Resonance images*
Computed Tomography images*
Computed Tomography images*
kV Cone-beam Computed Tomography image (first fraction)*
kV Cone-beam Computed Tomography image (first fraction)*
kV Cone-beam Computed Tomography image (last fraction)
kV Cone-beam Computed Tomography image (last fraction)*

 

 

Get in touch with our team

Whether you're looking to get started with SpaceOAR Hydrogel or have general questions about the product, procedure or clinical data, our team is here to help.

CONTACT US

 


 

Hear clinicians discuss SpaceOAR Vue Hydrogel’s impact on their practice and their patients.


 

 
Dr. Ed Soffen
Ed Soffen, MD, a Radiation Oncologist, talks about the potential benefits of SpaceOAR Vue Hydrogel with easier contouring, better visibility and time-saving efficiency.
Dr. Daniel Peterit
Radiation Oncologist, Daniel Petereit, MD, discusses how SpaceOAR Vue Hydrogel is designed to be highly visible in a CT scan and may be beneficial for patients who cannot undergo an MRI.
Dr. Alaina Rizzo
Alaina Rizzo, a Radiation Therapist at Princeton Radiation Oncology, talks about how SpaceOAR Vue Hydrogel can help visualize the hydrogel under cone-beam CT to better manage patient alignment.
Dr. Joseph Hanley
Joseph Hanley, Ph.D., Director of Medical Physics at Princeton Radiation Oncology, discusses how SpaceOAR Vue Hydrogel had a positive impact on meeting dose-volume constraints of treatment plans.

 

 

The benefits of SpaceOAR Vue Hydrogel


 
Radiopaque hydrogel allows visibility on CT scan
treatment planning can be done using CT only, reducing the need for MRI which may streamline workflow
CT visibility may hep reduce under-or over- contouring of the prostate and rectum for improved accuracy and optimized treatment planning
Radiopacity may provide a suitable imaging option to MRI for patients with implanted metallic devices allowing you to treat more patients

 

 

Real-world experience with SpaceOAR Vue Hydrogel

Dr. Elisha Fredman from the Davidoff Cancer Center and Rabin Medical Center in Petah Tikva, Israel shares his clinical experience with SpaceOAR Hydrogel Systems in his prostate cancer therapy approach.

 

Hear Dr. Fredman's conclusions >

View complete webinar on EDUCARE >


 
FAQ
Sign up for information

 

* Jeff Michalski, MD (2020). Permission granted by Washington University Imaging. 

1. Data on file with Boston Scientific

Caution: U.S. Federal law restricts this device to sale by or on the order of a physician.
CAUTION: The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings and instructions for use can be found in the product labeling supplied with each device. Information for use only in countries with applicable health authority registrations. This material not intended for use in France.
Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. Please check availability with your local sales representative or customer service.
SpaceOAR and SpaceOAR Vue Hydrogels are intended to temporarily position the anterior rectal wall away from the prostate during radiotherapy for prostate cancer and in creating this space it is the intent of SpaceOAR and SpaceOAR Vue Hydrogels to reduce the radiation dose delivered to the anterior rectum.
Prior to using these devices, please review the Instructions for Use for a complete listing of indications, contraindications, warnings, precautions and potential adverse events.
As with any medical treatment, there are some risks involved with the use of SpaceOAR and SpaceOAR Vue Hydrogels. Potential complications associated with SpaceOAR and SpaceOAR Vue Hydrogels include, but are not limited to: pain associated with SpaceOAR and SpaceOAR Vue Hydrogels injection; pain or discomfort associated with SpaceOAR and SpaceOAR Vue Hydrogels; needle penetration of the bladder, prostate, rectal wall, rectum or urethra; injection of SpaceOAR and SpaceOAR Vue Hydrogels into the bladder, prostate, rectal wall, rectum or urethra; local inflammatory reactions; infection; injection of air, fluid or SpaceOAR and SpaceOAR Vue Hydrogels intravascularly; urinary retention; rectal mucosal damage, ulcers, necrosis; bleeding; and rectal urgency. URO-989811-AA
All images are the property of Boston Scientific. All trademarks are the property of their respective owners.
Top